Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.
The Ashkenazi-Jewish population is at increased risk for several recessively inherited disorders. While some of the disorders have severe or fatal symptom manifestations, others, such as non-neuronopathic Gaucher disease, do not usually pose a serious, life-threatening illness. Many healthcare centers in Israel offer prenatal panel screening. Controversy exists over the inclusion of Gaucher disease in the panel screening, especially since Gaucher disease screening lacks prognostic reliability. Most screening participants do not discriminate between the specific tests in the panel and are unable to discern between severe, life-threatening diseases and those that are less severe and even treatable. By including screening for Gaucher in the panel screening program, there is risk of a "panel effect," leading to termination of a pregnancy positive for Gaucher disease, without sufficient knowledge and understanding of the disease. Increasing medical and public awareness and knowledge of the disease, its prognosis and treatment options may reduce the rate of under-informed abortions associated with prenatal screening for Gaucher disease.
Kannai
Ruth
R
Department of Family Medicine, University of Washington, Washington, USA. ruthyka@inter.net.il
Chertok
Ilana R
IR
D000025:Abortion, Eugenic / Q000941:ethics; D005260:Female; D005776:Gaucher Disease / Q000208:ethnology / Q000235:genetics*; D005820:Genetic Testing / Q000941:ethics*; D006801:Humans; D007585:Jews / Q000235:genetics*; D011247:Pregnancy; D011296:Prenatal Diagnosis / Q000941:ethics*; D012720:Severity of Illness Index